Voices of Vellore_Fall 2020

Page 1

VOICES FALL 2020

New York, NY | vellorecmc.org

of VELLORE

"I think India will have a big role in making SARS-Cov-2 vaccines for the world." - DR. PRIYA ABRAHAM Click here to watch the full interview with Dr. Abraham.

At the Forefront of the Fight Against COVID-19: Dr. Priya Abraham (Batch '81)

who are comfortable with whole genome sequencing. We've been able to look at 700 odd SARS-CoV-2 strains and have also generated about

I

n November 2019, just two months

Dr. Priya Abraham: Successfully isolating

before the first coronavirus case was

the virus in early March gave us the

detected in India, Dr. Priya Abraham

leverage to make our first indigenous

was appointed as the Director of the

ELISA (enzyme-linked immunosorbent

National Institute of Virology (NIV) in

assay), at a time when there were no

Pune, India. Since then, Dr. Abraham and

good serological assays.

her team have been actively engaged in

Another big benefit from our ability to

300 odd sequences to look at the profile of “clades” in our country. It was heartening to know that the real time polymerase chain reaction (PCR) assay that we put together was able to identify all these different varied strains, which meant it was robust enough as a

various aspects of the SARS-CoV-2 virus,

isolate and grow the virus was that we

diagnostic tool.

including diagnostic and vaccine-related

successfully propagated 11 or 12 strains

efforts.

in the laboratory - this contributed to

H: And have you been able to develop new rapid tests?

In an interview with Dr. Honorine

the development of a vaccine. We are

Ward (Batch ’69), Dr. Abraham discusses

working closely with Bharat Biotech on

NIV’s leading efforts in diagnostics and

a vaccine candidate. Apart from giving

vaccine development in India and her

them our strain, we have conducted

leadership at a prominent governmental

virus challenge experiments as part of

institution as a CMC alumna.

pre-clinical trials, which are essential to

Dr. Honorine Ward: You and your team at NIV were instrumental in isolating and sequencing one or more strains of the SARS-CoV-2 virus. How has this enabled NIV to work on developing diagnostics and vaccines for COVID-19?

vaccine development. With regard to sequencing, the first two sequences from India came out of the first three cases that were detected in this institute. I am privileged to work with great scientists

P: Right now, we do not have a rapid test, but we have developed a real time PCR Kit, where we have put together the probe, (continued on page 3) Dr. Ida B. Scudder Assisted Living Center On September 16th, the doors to the Center for retired CMC faculty and staff officially opened! Read more on page 4.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.